Table 2.
Description of cardiovascular outcomes
| Cardiometabolic factors | Consortium or study | Sample size# | Population | Year |
|---|---|---|---|---|
| Lipids | The Global Lipids Genetics | 188,578 | Trans-Ethnics | 2013 |
| Diseases | ||||
| CAD | CARDIoGRAM and CARDIoGRAMplusC4D | 60,801/123,504 | Trans-Ethnics | 2015 |
| MI | CARDIoGRAM and CARDIoGRAMplusC4D | 43,676/128,197 | Trans-Ethnics | 2015 |
| Stroke | SiGN and ISGC | 37,792/397,209 | Trans-Ethnics | 2016 |
#Reports total sample size or case/controls;
Lipids include high density lipoprotein (mg/dL), low density lipoprotein (mg/dL), total cholesterol (mg/dL), triglycerides (mg/dL)
CAD: coronary artery disease; MI: myocardial infarction; CARDIoGRAMplusC4D: the Coronary ARtery DIsease Genome wide Replication and Meta-analysis (CARDIoGRAM) plus the Coronary Artery Disease (C4D) Genetics (CARDIoGRAMplusC4D) consortium; SiGN: the NINDS Stroke Genetics Network; ISGC: International Stroke Genetics Consortium